Research ArticleBasic Science Investigations
PET of EGFR Expression with an 18F-Labeled Affibody Molecule
Zheng Miao, Gang Ren, Hongguang Liu, Shibo Qi, Song Wu and Zhen Cheng
Journal of Nuclear Medicine July 2012, 53 (7) 1110-1118; DOI: https://doi.org/10.2967/jnumed.111.100842
Zheng Miao
Gang Ren
Hongguang Liu
Shibo Qi
Song Wu

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 53, Issue 7
July 1, 2012
PET of EGFR Expression with an 18F-Labeled Affibody Molecule
Zheng Miao, Gang Ren, Hongguang Liu, Shibo Qi, Song Wu, Zhen Cheng
Journal of Nuclear Medicine Jul 2012, 53 (7) 1110-1118; DOI: 10.2967/jnumed.111.100842
Jump to section
Related Articles
Cited By...
- Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
- Preparation and Evaluation of 99mTc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors
- Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment
- Metabolism of Epidermal Growth Factor Receptor Targeting Probe [11C]PD153035: Impact on Biodistribution and Tumor Uptake in Rats
- Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics